News
Sword Health launches bloom: a new pelvic pain product

SWORD Health has launched Bloom, a physical therapy product aimed at women struggling with pelvic pain
Bloom is a clinical-grade digital solution aimed at women’s physical health issues. It will help to provide non-invasive care for neglected health issues such as pelvic pain or postpartum recovery. Worldwide, The rates of chronic pelvic pain for women of childbearing age range from 14 per cent to 32 per cent globally.
It includes a sensor that will measure the pressure and stamina of a person’s pelvic floor while connecting to an app so that users can receive feedback on their exercises. Patients will then be paired with a pelvic health specialist who will guide them through exercises or tailor the program to suit their needs.
It is hoped that Bloom will help to reduce chronic pain and dysfunction in turn decreasing the need for painkillers or invasive options, like surgery.
Bloom and pelvic pain
Marta Cardeano, general manager of Bloom said: “I’ve suffered many years with pelvic pain, and it’s now an honour to build this solution that will help thousands of women across the world. Just like me, many women simply don’t know there are solutions that can help free them from pain.
We are here to support the female population with effective and non-invasive solutions to improve their quality of life. Bloom technology is providing a new way for women to address their pelvic disorders from the privacy and convenience of their homes.”
Virgilio Bento, CEO of SWORD Health said: “Women’s physical health has been an overlooked problem in healthcare for decades. Right now, one in every four women suffers from pelvic disorders, without being able to access a solution that is both clinically effective and convenient.
That’s why we’ve decided to launch Bloom: we believe every woman should be able to have access to the best care and not suffer in silence. After developing the new gold standard of care for back and joint pain, Bloom is our next step towards fulfilling our mission to free two billion people from pain”.
Insight
PCOS renamed after decade-long campaign to end ‘cyst’ misconception
Fertility
Housing, work and fertility stop Britons having the families they want – research
Fertility
Femtech World reveals fertility innovation award shortlist

Femtech World is thrilled to reveal the shortlist for the Fertility Innovation Award.
The award, sponsored by FinDBest IVF, celebrates a pioneering product, service or initiative that is transforming fertility care and support.
FinDBest IVF is a global B2B digital platform created to simplify and accelerate how IVF and ART manufacturers connect with trusted, pre-vetted distributors around the world.
This year’s nominees represent a remarkable breadth of approaches to fertility care: from clinic-floor breakthroughs to at-home hormone intelligence to truly borderless access.
Three companies made the cut, with each tackling a real, persistent barrier in reproductive health.
Congratulations to the shortlist and many thanks to everyone who entered.
Fertility Innovation Award Shortlist

HRC Fertility’s Needle-Free IVF is a pioneering advancement designed to transform one of the most challenging aspects of fertility treatment: daily hormone injections.
Developed by board-certified reproductive endocrinologist Dr Rachel Mandelbaum, this innovative approach reimagines how stimulation medications are delivered during IVF and egg freezing, dramatically improving the patient experience while maintaining the same trusted clinical outcomes.
Inspired by feedback from patients who struggled with the injection process, Dr Mandelbaum adapted an innovative drug-delivery system commonly used in other areas of medicine and applied it to reproductive care

Mira is a hormonal health technology company that provides lab-grade hormone testing and AI-driven insights to help women and couples understand their fertility.
The platform has already supported more than 200,000 couples on their fertility journeys worldwide, helping over 60,000+ users achieve pregnancy.
For some users, pregnancy rates have reached up to 89 per cent within six months, demonstrating how accurate hormone data can significantly improve fertility outcomes.

Founded in 2021 by Marija Skujina, a Certified Fertility Nurse Specialist accredited by the European Society of Human Reproduction and Embryology, with nearly 15 years of clinical experience at one of the world’s top IVF clinics, and having navigated her own fertility journey as a patient, Marija built the clinic she had always wished existed.
Plan Your Baby began with a bold, but simple mission – make best quality fertility and pregnancy available anywhere.
Plan Your Baby has created a new generation fertility and pregnancy clinic with patients accessing expert consultations remotely, while blood tests and ultrasound scans are available at over 450 locations across the UK, eliminating the exhausting travel burden that often forces people to take days off work, relocate appointments, or abandon treatment altogether
What happens now
The shortlist will be judged by a representative from category sponsor FindBestIVF, with the winner announced at a virtual event on June 19.
Winners will receive a trophy and be interviewed by a Femtech World journalist.
Entrepreneur3 weeks agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
Entrepreneur2 weeks agoWomen’s digital health market set to reach US$5.28 billion in 2026 – report
Fertility4 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Diagnosis3 weeks agoNew meta-analysis further supports low re-excisions and high placement accuracy with the Magseed marker
Menopause4 weeks agoMore research needed to understand link between brain fog and menopause, expert says
Mental health3 weeks agoLifting weights shows mental health and cognitive benefits in older women, study finds
Entrepreneur4 weeks agoFlora Fertility closes US$5m seed round
News3 weeks agoResistance training has preventative effects in menopause, study finds














